Genmab A (GMAB) Non-Current Deffered Revenue (2023 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Genmab A (GMAB) has disclosed Non-Current Deffered Revenue for 2 consecutive years, with $67.0 million as the latest value for Q4 2024.

• For the quarter ending Q4 2024, Non-Current Deffered Revenue fell 5.63% year-over-year to $67.0 million, compared with a TTM value of $67.0 million through Dec 2024, down 5.63%, and an annual FY2024 reading of $67.0 million, down 5.63% over the prior year.
• Non-Current Deffered Revenue was $67.0 million for Q4 2024 at Genmab A, down from $71.0 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $71.0 million in Q4 2023 and bottomed at $67.0 million in Q4 2024.

Peer Comparison